Regenxbio: Fourth Quarter Financial Overview

Regenxbio Inc. Reports Fourth Quarter Financial Results

Regenxbio Inc., headquartered in Rockville, Maryland, announced on Thursday that it recorded a net loss of $67.1 million for the fourth quarter.

The company reported a quarterly loss of $1.30 per share.

These figures fell short of analysts' expectations, as a consensus of six analysts polled by Zacks Investment Research had anticipated a loss of $1.01 per share.

During the same period, Regenxbio generated $30.3 million in revenue, which was below the $31.5 million forecasted by five Zacks analysts.

For the full year, Regenxbio reported a total loss of $193.9 million, or $3.76 per share, with annual revenue reaching $170.4 million.

This article was produced by Automated Insights using financial data from Zacks Investment Research.